Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 4 (2007), Issue 11 (November)

1. Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor.
   Neurochem Res, 32(12): 2235-42. [Abstract] [Full-text]
2. Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis.
   Neurochem Res, 32(12): 2167-83. [Abstract] [Full-text]
3. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.
   Neurochem Res, 32(12): 2203-9. [Abstract] [Full-text]
4. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells.
   Neurochem Res, 32(12): 2094-102. [Abstract] [Full-text]
5. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
   Neurochem Res, 32(12): 2194-202. [Abstract] [Full-text]
6. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells.
   Neurochem Res, 32(12): 2103-13. [Abstract] [Full-text]
7. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
   Mutat Res, 625(1): 134-44. [Abstract] [Full-text]
8. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.
   Pharm Res, 24(12): 2309-16. [Abstract] [Full-text]
9. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
   J Natl Cancer Inst, 99(21): 1583-93. [Abstract] [Full-text]
10. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
    J Control Release, 124(3): 163-71. [Abstract] [Full-text]
11. Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.
    Radiology, 245(3): 824-30. [Abstract] [Full-text]
12. Increased expression of intracystic matrix metalloproteinases in brain tumors: relationship to the pathogenesis of brain tumor-associated cysts and peritumoral edema.
    J Clin Neurosci, 14(12): 1192-8. [Abstract] [Full-text]
13. Cranial nerve palsies accompanying pituitary tumour.
    J Clin Neurosci, 14(12): 1158-62. [Abstract] [Full-text]
14. Biology of the subventricular zone in relation to gliomagenesis.
    J Clin Neurosci, 14(12): 1143-9. [Abstract] [Full-text]
15. Calcified vestibular schwannoma in the cerebellopontine angle.
    J Clin Neurosci, 14(12): 1207-9. [Abstract] [Full-text]
16. Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?
    Pediatr Blood Cancer, 50(1): 163-6. [Abstract] [Full-text]
17. Bilateral germinoma of the basal ganglia.
    Pediatr Blood Cancer, 50(1): 177-9. [Abstract] [Full-text]
18. Cerebellar medullomyoblastoma with melanotic tubular structures.
    Pediatr Blood Cancer, 50(1): 183-5. [Abstract] [Full-text]

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.